Global Ascites Market Opportunities and Forecast 2020-2027

Global Ascites Market, By Diagnosis (R-Ray, Physical Examination, Ultrasound and CT Scan), By Treatment (Chemotherapy, Diuretic, Paracentesis, Surgeries and Others) By End User (Hospital, ASC, Cardiology Center) opportunities and forecast 2020-2027

Market Overview

Accumulation of the fluid in peritoneal cavity that is, the space between the lining of abdominal and abdomen organs, is denoted as ascites. Liver cirrhosis is the common case of ascites. Incidence of ascites is sign of important portal hypertension. The high pressure in the blood vessels of the liver and low levels of the albumin results in ascites. Moreover, less common aspects such as kidney failure, infection in pancreas, cancers and heart failure could contribute to ascites development.

Rise in the prevalence of liver cirrhosis is projected to drive the global market. Additionally, surge in number of the patients suffering from the liver cirrhosis due to rise in alcohol consumption is anticipated to drive global market. Rise in the cases of cancer and progress in reimbursement also boost growth of global market. Though, complications related with the disease treatment is one of factors expected to restrain global ascites market.

Segment Overview

The ascites market can be segmented on the basis of type, diagnosis, and treatment. Based on diagnosis, the market can be divided into ultrasound, angiography, CT scan, laparoscopy, and others.

The ultrasound segment is expected to grow at a fast pace over the forecast period. Based on the treatment, market can be categorised into paracentesis, medicinal therapy, liver transplantation, and others. Based on end-user, the global market can be segmented into clinics, hospitals, diagnostics centers, ambulatory surgical centers, and others.

Regional Overview

North America lead the global market in 2019 due to the developed technologies, high health care expenditure, rise in incidence of cirrhosis, and occurrence of leading players in region. Increasing awareness about the ascites diagnostic test and the related treatments is expected to drive market in Europe. Moreover, skilled health care specialists, increase in alcohol consumption, and the obesity are the major factors to expect to propel ascites market in region over the forecast period.

Moreover, rise in incidence of cirrhosis and increase in the number of surgeries are expected to augment the market in the region.
Asia Pacific is projected to be the fastest developing market for disease treatment owing to surge in awareness around ascites and associated treatment, fast developing health care arrangement, and increase in the literacy rate. Poor economy and the inadequate health care arrangement are likely to hamper growth of the market in Middle East & Africa.

Competitor overview

The global market is extremely fragmented due to presence of large number of local and global players. Focus on advanced treatment options is anticipated to drive global market over the forecast period. Major players operating in the market are PharmaCyte, Sofinnova, Sequana Medical NV, Biotech Inc., BioVie, Inc., Medtronic plc, Becton, Dickinson and Company, GI Supply, Fresenius SE & Co. KGaA, QED Bioscience, Inc., and Abcore, Inc.

Key Players

1. Sofinnova,
2. PharmaCyte, Biotech Inc.,
3. Sequana Medical NV,
4. BioVie, Inc., Becton,
5. Dickinson and Company,
6. Medtronic plc,
7. GI Supply,
8. QED Bioscience, Inc.,
9. Fresenius SE & Co. KGaA,
10. Abcore, Inc.

Market Segmentation

By Diagnosis

• X-Ray Test,
• Physical Examination,
• Ultrasound
• CT scans

By Treatment

• Diuretics,
• Chemotherapy,
• Paracentesis
• Surgeries

By Geography

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • UAE
  • Rest of LAMEA